Showing results (301-310 of 1,013) with videos related to

Sort By:
Pageof 102
Lancet Regional Health. Americas|August 8, 2025
Safety and tolerability of onasemnogene abeparvovec for patients with spinal muscular atrophy weighing ≤17 kg and ≤24 months old from OFELIA, a phase 4, open-label, multicenter, non-randomised, interventional studyJonas Alex Saute, Javier Muntadas, Juliana Gurgel-Giannetti, et al.
Lancet Regional Health. Americas|September 17, 2025
The significant impact of meconium ileus on clinical outcomes among Brazilian individuals with cystic fibrosis-a retrospective analysis of a patient registryLuiz Vicente Ribeiro F da Silva-Filho, Gianluca Belchior, Angela Tavares Paes, et al.
Lancet Regional Health. Americas|September 22, 2025
The cost-effectiveness of tafenoquine following screening with STANDARD™ G6PD screening for the treatment of vivax malaria in the Brazilian Public Health SystemHenry Maia Peixoto, Luiza Lena Bastos Gottin, Jose Diego de Brito-Sousa, et al.
Lancet Regional Health. Americas|September 22, 2025
Risk factors and survival impact of severe radiation-related late toxicities in head and neck cancer-a cohort studyJohn Mohan Mathew, Jolie Ringash, Jie Su, et al.
Lancet Regional Health. Americas|October 24, 2025
Political economy of primary health care resilience in Latin America and the Caribbean: insights from the WB/PAHO Commission recommendationsErnesto Báscolo, Natalia Houghton, Sara Bennett
Lancet Regional Health. Americas|October 24, 2025
Community-driven strategies for primary health care resilience in response to shocks in Latin America and the Caribbean: a scoping review and expert consultationNatalia Houghton, Ernesto Bascolo, Claudia Zavaleta, et al.
Lancet Regional Health. Americas|October 24, 2025
Corrigendum to "Healthy Brazil: a multisectoral strategy for tackling neglected diseases and promoting health equity"- The Lancet Regional Health-Americas 2025; Volume 48, 101187; DOI: 10.1016/j.lana.2025.101187
Lancet Regional Health. Americas|July 23, 2025
Carbapenemases producing gram-negative bacteria surveillance in Latin America and the caribbean: a retrospective observational study from 2015 to 2020Marcelo Pillonetto, Priscila Lamb Wink, Roberto G Melano, et al.
Lancet Regional Health. Americas|March 24, 2025
Approaching pediatric mental health screening and care in immigration detentionShela Sridhar, Leah Ratner, Matthew G Gartland, et al.
Lancet Regional Health. Americas|January 9, 2023
Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-Plus: a double-blind, randomised, placebo-controlled phase 3 clinical trialMaría Eugenia Toledo-Romaní, Mayra García-Carmenate, Carmen Valenzuela-Silva, et al.
Pageof 102